Review



cpass sars-cov-2 surrogate vnt kit  (GenScript corporation)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    GenScript corporation cpass sars-cov-2 surrogate vnt kit
    Proportion of samples per German federal state (left) and per wild ruminant species (right) that reacted positive (red) in an receptor‐binding domain‐based severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) antibody ELISA. In the lower right panel, the number of sero‐reactive results/number of analysed samples is given separately for each federal state and, if known, the hunting district from which the samples originated. The serum that additionally tested positive in a surrogate <t>virus</t> <t>neutralisation</t> <t>test</t> is framed in red. BY–Bavaria, HE–Hesse, MV–Mecklenburg‐Western Pomerania, NW–North Rhine‐Westphalia, RP–Rhineland‐Palatinate
    Cpass Sars Cov 2 Surrogate Vnt Kit, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cpass sars-cov-2 surrogate vnt kit/product/GenScript corporation
    Average 90 stars, based on 1 article reviews
    cpass sars-cov-2 surrogate vnt kit - by Bioz Stars, 2026-05
    90/100 stars

    Images

    1) Product Images from "Serological screening in wild ruminants in Germany, 2021/2022: No evidence of SARS‐CoV‐2, bluetongue virus or pestivirus spread but high seroprevalences against Schmallenberg virus"

    Article Title: Serological screening in wild ruminants in Germany, 2021/2022: No evidence of SARS‐CoV‐2, bluetongue virus or pestivirus spread but high seroprevalences against Schmallenberg virus

    Journal: Transboundary and Emerging Diseases

    doi: 10.1111/tbed.14600

    Proportion of samples per German federal state (left) and per wild ruminant species (right) that reacted positive (red) in an receptor‐binding domain‐based severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) antibody ELISA. In the lower right panel, the number of sero‐reactive results/number of analysed samples is given separately for each federal state and, if known, the hunting district from which the samples originated. The serum that additionally tested positive in a surrogate virus neutralisation test is framed in red. BY–Bavaria, HE–Hesse, MV–Mecklenburg‐Western Pomerania, NW–North Rhine‐Westphalia, RP–Rhineland‐Palatinate
    Figure Legend Snippet: Proportion of samples per German federal state (left) and per wild ruminant species (right) that reacted positive (red) in an receptor‐binding domain‐based severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) antibody ELISA. In the lower right panel, the number of sero‐reactive results/number of analysed samples is given separately for each federal state and, if known, the hunting district from which the samples originated. The serum that additionally tested positive in a surrogate virus neutralisation test is framed in red. BY–Bavaria, HE–Hesse, MV–Mecklenburg‐Western Pomerania, NW–North Rhine‐Westphalia, RP–Rhineland‐Palatinate

    Techniques Used: Binding Assay, Enzyme-linked Immunosorbent Assay, Virus, Western Blot



    Similar Products

    cpass sars-cov-2 surrogate vnt kit  (GenScript corporation)
    90
    GenScript corporation cpass sars-cov-2 surrogate vnt kit
    Proportion of samples per German federal state (left) and per wild ruminant species (right) that reacted positive (red) in an receptor‐binding domain‐based severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) antibody ELISA. In the lower right panel, the number of sero‐reactive results/number of analysed samples is given separately for each federal state and, if known, the hunting district from which the samples originated. The serum that additionally tested positive in a surrogate <t>virus</t> <t>neutralisation</t> <t>test</t> is framed in red. BY–Bavaria, HE–Hesse, MV–Mecklenburg‐Western Pomerania, NW–North Rhine‐Westphalia, RP–Rhineland‐Palatinate
    Cpass Sars Cov 2 Surrogate Vnt Kit, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cpass sars-cov-2 surrogate vnt kit/product/GenScript corporation
    Average 90 stars, based on 1 article reviews
    cpass sars-cov-2 surrogate vnt kit - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    cpass sars-cov-2 neutralizing antibody detection kit, surrogate vnt, svnt  (GenScript corporation)
    90
    GenScript corporation cpass sars-cov-2 neutralizing antibody detection kit, surrogate vnt, svnt
    Relationship between the immunogenicity assays in 79 participants who are full vaccinated with AZD1222 ( a ) value of S/Co of anti-S1 antibody and <t>sVNT</t> (%) ( b ) Spots of Discovery SARS-CoV-2 kit S1 panel and sVNT. S/Co; signal to cut-off, sVNT; surrogate virus neutralization test.
    Cpass Sars Cov 2 Neutralizing Antibody Detection Kit, Surrogate Vnt, Svnt, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cpass sars-cov-2 neutralizing antibody detection kit, surrogate vnt, svnt/product/GenScript corporation
    Average 90 stars, based on 1 article reviews
    cpass sars-cov-2 neutralizing antibody detection kit, surrogate vnt, svnt - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Proportion of samples per German federal state (left) and per wild ruminant species (right) that reacted positive (red) in an receptor‐binding domain‐based severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) antibody ELISA. In the lower right panel, the number of sero‐reactive results/number of analysed samples is given separately for each federal state and, if known, the hunting district from which the samples originated. The serum that additionally tested positive in a surrogate virus neutralisation test is framed in red. BY–Bavaria, HE–Hesse, MV–Mecklenburg‐Western Pomerania, NW–North Rhine‐Westphalia, RP–Rhineland‐Palatinate

    Journal: Transboundary and Emerging Diseases

    Article Title: Serological screening in wild ruminants in Germany, 2021/2022: No evidence of SARS‐CoV‐2, bluetongue virus or pestivirus spread but high seroprevalences against Schmallenberg virus

    doi: 10.1111/tbed.14600

    Figure Lengend Snippet: Proportion of samples per German federal state (left) and per wild ruminant species (right) that reacted positive (red) in an receptor‐binding domain‐based severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) antibody ELISA. In the lower right panel, the number of sero‐reactive results/number of analysed samples is given separately for each federal state and, if known, the hunting district from which the samples originated. The serum that additionally tested positive in a surrogate virus neutralisation test is framed in red. BY–Bavaria, HE–Hesse, MV–Mecklenburg‐Western Pomerania, NW–North Rhine‐Westphalia, RP–Rhineland‐Palatinate

    Article Snippet: Wildlife samples that reacted positive in the RBD‐ELISA were subsequently tested by a virus neutralisation test (VNT) against the SARS‐CoV‐2 strain 2019_nCoV Muc‐IMB‐1 performed as described previously (Schlottau et al., ) and by a surrogate VNT (cPass SARS‐CoV‐2 Surrogate VNT Kit, GenScript).

    Techniques: Binding Assay, Enzyme-linked Immunosorbent Assay, Virus, Western Blot

    Relationship between the immunogenicity assays in 79 participants who are full vaccinated with AZD1222 ( a ) value of S/Co of anti-S1 antibody and sVNT (%) ( b ) Spots of Discovery SARS-CoV-2 kit S1 panel and sVNT. S/Co; signal to cut-off, sVNT; surrogate virus neutralization test.

    Journal: Vaccines

    Article Title: Immunogenicity after Second ChAdOx1 nCoV-19 (AZD1222) Vaccination According to the Individual Reactogenicity, Health Status and Lifestyle

    doi: 10.3390/vaccines9121473

    Figure Lengend Snippet: Relationship between the immunogenicity assays in 79 participants who are full vaccinated with AZD1222 ( a ) value of S/Co of anti-S1 antibody and sVNT (%) ( b ) Spots of Discovery SARS-CoV-2 kit S1 panel and sVNT. S/Co; signal to cut-off, sVNT; surrogate virus neutralization test.

    Article Snippet: Therefore, we utilized the cPASS SARS-CoV-2 neutralizing antibody detection kit, surrogate VNT, sVNT (Genscript Biotech Corporation, Piscataway, NJ, USA), which is known to have a high correlation with the PRNT [ , ].

    Techniques: Immunopeptidomics, Virus, Neutralization